Recruiting Atopic Dermatitis Studies in Webster
XTX301 in Patients With Advanced Solid Tumors
This is a first-in-human, multicenter, Phase 1/2, open-label study designed to evaluate the safety and tolerability of XTX301 as monotherapy in patients with advanced solid tumors....
Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis
This is a randomized, placebo-controlled and double-blind study to evaluate the efficacy, pharmacokinetics, and Safety of repeat subcutaneous doses of FB825 in adults with moderate-to-severe atopic de...
About Atopic Dermatitis Clinical Trials in Webster
Atopic dermatitis (eczema) is a chronic inflammatory skin condition causing itchy, red, and dry skin. It is the most common form of eczema, often beginning in childhood. Treatment includes moisturizers, topical corticosteroids, immunomodulators, and newer biologics like dupilumab.
There are currently 2 atopic dermatitis clinical trials recruiting participants in Webster, TX. These studies are seeking a combined 448 participants. Research is being sponsored by Xilio Development, Inc., Oneness Biotech Co., Ltd.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Atopic Dermatitis Clinical Trials in Webster — FAQ
Are there atopic dermatitis clinical trials in Webster?
Yes, there are 2 atopic dermatitis clinical trials currently recruiting in Webster, TX. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Webster?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Webster research site will contact you about next steps.
Are clinical trials in Webster free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Webster studies also compensate for your time and travel.
What atopic dermatitis treatments are being tested?
The 2 active trials in Webster are testing new therapies including novel drugs, biologics, and treatment approaches for atopic dermatitis.
Data updated March 2, 2026 from ClinicalTrials.gov